14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia

PLoS One. 2015 Jul 6;10(7):e0131074. doi: 10.1371/journal.pone.0131074. eCollection 2015.

Abstract

The down-modulation of the β-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion gene of chronic myeloid leukemia (CML) contributes to the aberrant activation of β-catenin, particularly in leukemic stem cells (LSC) resistant to tyrosine kinase (TK) inhibitors. It is, at least partly, driven by transcriptional events and gene promoter hyper-methylation. Here we demonstrate that it also arises from reduced protein stability upon binding to 14-3-3σ adapter protein. CBY1/14-3-3σ interaction in BCR-ABL1+ cells is mediated by the fusion protein TK and AKT phosphorylation of CBY1 at critical serine 20, and encompasses the 14-3-3σ binding modes I and II involved in the binding with client proteins. Moreover, it is impaired by c-Jun N-terminal kinase (JNK) phosphorylation of 14-3-3σ at serine 186, which promotes dissociation of client proteins. The ubiquitin proteasome system UPS participates in reducing stability of CBY1 bound with 14-3-3σ through enhanced SUMOylation. Our results open new routes towards the research on molecular pathways promoting the proliferative advantage of leukemic hematopoiesis over the normal counterpart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins / metabolism*
  • Amino Acid Motifs
  • Benzamides / pharmacology
  • Biomarkers, Tumor / metabolism*
  • Carrier Proteins / biosynthesis*
  • Carrier Proteins / genetics
  • Down-Regulation
  • Exoribonucleases / metabolism*
  • Fusion Proteins, bcr-abl / metabolism
  • Gene Expression Regulation, Leukemic / genetics*
  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Nuclear Proteins / biosynthesis*
  • Nuclear Proteins / genetics
  • Oncogene Protein p65(gag-jun)
  • Phosphorylation
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Binding
  • Protein Interaction Mapping
  • Protein Processing, Post-Translational*
  • Protein Stability
  • Proto-Oncogene Proteins c-akt / metabolism
  • Pyrazoles / pharmacology
  • Subcellular Fractions / metabolism
  • Sumoylation
  • beta Catenin / antagonists & inhibitors

Substances

  • 14-3-3 Proteins
  • BCR-ABL1 fusion protein, human
  • BV02 compound
  • Benzamides
  • Biomarkers, Tumor
  • CBY1 protein, human
  • CTNNB1 protein, human
  • Carrier Proteins
  • Neoplasm Proteins
  • Nuclear Proteins
  • Oncogene Protein p65(gag-jun)
  • Pyrazoles
  • beta Catenin
  • Fusion Proteins, bcr-abl
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt
  • JNK Mitogen-Activated Protein Kinases
  • Exoribonucleases
  • SFN protein, human
  • Proteasome Endopeptidase Complex